当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3878432
自主品牌
已选条件
-
TP2112LTC14012 acetateTC-14012 acetate,TC14012 acetate
TC14012 acetate is a serum-stable derivative of T140 which is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is also a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-cancer activity and anti-HIV activity.
价 格：￥电议型 号：TP2112L产 地：中国大陆
-
T83769TC 14012 hydrochloride；化合物 TC 14012 hydrochlorideH-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-D-Cit-Pro-Tyr-Arg-Cit
TC 14012, a peptidomimetic compound, acts as both an antagonist to the chemokine (C-X-C motif) receptor 4 (CXCR4; IC50 = 2.9 nM) and as an agonist for CXCR7, effectively recruiting β-arrestin in HEK293T cells that express CXCR7 (EC50 = 350 nM). Moreover, it demonstrates significant antiviral activity by reducing the cytopathic effects of HIV in MT-4 cells with an EC50 value of 0.4 nM and inhibiting HIV entry in vitro through a CXCR4-dependent pathway (IC50 = 19.3 nM). Additionally, TC 14012 supp
价 格：￥电议型 号：T83769产 地：中国大陆
-
T75801TC14012 TFA；化合物 TC14012 TFATC14012 TFA
TC14012 TFA, a serum-stable derivative of T140, is a selective peptidomimetic CXCR4 antagonist with an IC50 value of 19.3 nM. It also acts as a potent CXCR7 agonist, exhibiting an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. This compound demonstrates anti-HIV and anti-cancer activities [1] [2].
价 格：￥电议型 号：T75801产 地：中国大陆
-
T34061Picobenzide；化合物 T34061M 14012-4|||MA 14012；M 14012-4|||MA 14012
Picobenzide, also known as M-14012-4, is a neuroleptic agent,
价 格：￥电议型 号：T34061产 地：中国大陆
-
T140122-(Azido-PEG2-amido)-1,3-propandiol；化合物 T140122-(Azido-PEG2-amido)-1,3-propandiol
2-(Azido-PEG2-amido)-13-propandiol is a Polyethylene glycol (PEG)-based PROTAC linker used for the synthesis of PROTACs[1].
价 格：￥电议型 号：T14012产 地：中国大陆
-
T10221LAbeprazan；化合物 T10221LDWP14012|||Abeprazan|||DWP-14012|||DWP14012|||DWP 14012|||DWP14012|||Abeprazan；
Abeprazan (DWP14012) is a potassium-competitive acid blocker and it is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases[1]. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required.
价 格：￥电议型 号：T10221L产 地：中国大陆
